BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37688768)

  • 1. TIMP1 shapes an immunosuppressive microenvironment by regulating anoikis to promote the progression of clear cell renal cell carcinoma.
    Li Q; Wei K; Zhang X; Lv Y; Li M; Zhou C; Su S; Hou D; Hou J
    Aging (Albany NY); 2023 Sep; 15(17):8908-8929. PubMed ID: 37688768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.
    He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma.
    Liu Y; Shi Z; Zheng J; Zheng Z; Sun H; Xuan Z; Bai Y; Fu M; Du Y; Shao C
    Front Immunol; 2023; 14():1171883. PubMed ID: 37056778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma.
    Wei K; Zhang X; Yang D
    PeerJ; 2023; 11():e16643. PubMed ID: 38130918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated single-cell and bulk characterization of branched chain amino acid metabolism-related key gene BCAT1 and association with prognosis and immunogenicity of clear cell renal cell carcinoma.
    Zheng J; Liu Y; Wang J; Shi J; Li L; Jiang X; Tao L
    Aging (Albany NY); 2024 Feb; 16(3):2715-2735. PubMed ID: 38309289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma.
    Chen Z; Liu X; Zhu Z; Chen J; Wang C; Chen X; Zhu S; Zhang A
    Front Genet; 2022; 13():1039465. PubMed ID: 36338978
    [No Abstract]   [Full Text] [Related]  

  • 7. Anoikis-related genes signature development for clear cell renal cell carcinoma prognosis and tumor microenvironment.
    Jiang Y; Wang Y; Wang Z; Zhang Y; Hou Y; Wang X
    Sci Rep; 2023 Nov; 13(1):18909. PubMed ID: 37919386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and identification of anoikis-related lncRNA signatures for improving prognosis in clear cell renal cell carcinoma.
    Zhu Z; Wang Q; Zeng X; Zhu S; Chen J
    Aging (Albany NY); 2024 Feb; 16(4):3915-3933. PubMed ID: 38385949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an immune-related eRNA prognostic signature for clear cell renal cell carcinoma.
    Lv Y; Niu L; Li Q; Shao W; Yan X; Li Y; Yue Y; Chen H
    Aging (Albany NY); 2024 Jan; 16(3):2232-2248. PubMed ID: 38289619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting prognosis, immunotherapy and distinguishing cold and hot tumors in clear cell renal cell carcinoma based on anoikis-related lncRNAs.
    Hao C; Li R; Lu Z; He K; Shen J; Wang T; Qiu T
    Front Immunol; 2023; 14():1145450. PubMed ID: 37359524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PYCR1 regulates glutamine metabolism to construct an immunosuppressive microenvironment for the progression of clear cell renal cell carcinoma.
    Wei X; Zhang X; Wang S; Wang Y; Ji C; Yao L; Song N
    Am J Cancer Res; 2022; 12(8):3780-3798. PubMed ID: 36119844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma.
    Chen J; Sun M; Chen C; Kang M; Qian B; Sun J; Ma X; Zhou J; Huang L; Jiang B; Fang Y
    Front Immunol; 2023; 14():1135617. PubMed ID: 37081871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Crotonylation Metabolism Signature Predicting Overall Survival for Clear Cell Renal Cell Carcinoma.
    Zheng J; Liu Y; Wei K; Shi J; Li L; Jiang X; Tao L
    Int J Clin Pract; 2023; 2023():5558034. PubMed ID: 38058677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of anoikis-related subtypes and immune landscape in kidney renal clear cell carcinoma.
    Ding W; Zhang M; Zhang P; Zhang X; Sun J; Lin B
    Sci Rep; 2023 Oct; 13(1):18069. PubMed ID: 37872217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of anoikis-related genes to clarify the prognosis and immune mechanisms of patients with low-grade glioma.
    Wang J; Liu Y; Qian M; Xu W; Chen J; Deng Y; Luo R; Chen J; Jia W; Liu L; Tian C
    Biochem Biophys Res Commun; 2024 Jun; 711():149894. PubMed ID: 38603834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
    Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
    Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of SLCO4C1 as a biological marker in hepatocellular carcinoma based on anoikis classification features.
    Wang T; Guo K; Yang S; Zhang D; Cui H; Yin J; Yuan S; Wang Y; Qi Y; Wu W
    Aging (Albany NY); 2024 Jan; 16(2):1440-1462. PubMed ID: 38226966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma.
    Tan D; Miao D; Zhao C; Shi J; Lv Q; Xiong Z; Yang H; Zhang X
    BMC Cancer; 2023 Mar; 23(1):264. PubMed ID: 36949462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Tian J; Cheng C; Gao J; Fu G; Xu Z; Chen X; Wu Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma.
    Fu L; Bao J; Li J; Li Q; Lin H; Zhou Y; Li J; Yan Y; Langston ME; Sun T; Guo S; Zhou X; Chen Y; Liu Y; Zhao Y; Lu J; Huang Y; Chen W; Chung BI; Luo J
    Front Immunol; 2022; 13():1021935. PubMed ID: 36248876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.